December 18, 2020
Pharmaceutical company Regeneron raked in ill-gotten gains by making charitable donations to offset the price patients paid for a vision loss drug — all while insurers remained on the hook for the higher price, insurance company UnitedHealthcare alleged in a suit Thursday.